Visual Acuity: Clinical Trials

5 trials for Visual Acuity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 3, Not yet recruiting 1, Unknown 1

Follow Visual Acuity: new trials by email Literature Review of Visual Acuity trials Research Report on Visual Acuity

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Evaluation of Visual Performance, Spectacle Independence, and Patient Satisfaction With TECNIS PureSee Mini-Monovision and TECNIS PureSee-TECNIS Odyssey Mix-Match
TECNIS PureSee IOL (Model DEN00V/DET150), TECNIS Odyssey IOL (Model DRN00V/DRT150) - Presbyopia Correction, Presbyopia
Phase 4Not yet recruitingDr. Daniel H. Chang, MD682026-10-012026-10-06
Treating Lid Wiper Epitheliopathy
Preservative Free eye drop - Dry Eye, Visual Acuity
Phase 4CompletedSouthern College of Optometry522024-05-272025-02-25
Clinical Evaluation of Two Marketed Artificial Tears in Non-contact Lens Wearing Patients
Test Eye Drops, Control Eye Drops - Visual Acuity
Phase 4CompletedJohnson & Johnson Vision Care, Inc.572018-02-092019-06-28
Evaluation of Electronic LogMar Visual Acuity and Contrast Sensitivity in a Population of Contact Lens Wearers
senofilcon A, Control - Visual Acuity
Phase 4CompletedJohnson & Johnson Vision Care, Inc.492017-06-272019-09-10
Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration
Ranibizumab - Macular Degeneration, Visual Acuity
Phase 4UnknownMcGill University Health Centre/Research Institute of the McGill University Health Centre1802009-01-012008-12-23

Narrower conditions

Cataract (1)  ·  Dry Eye Syndromes (1)  ·  Macular Degeneration (1)  ·  Presbyopia (1)

Broader conditions

Eye Diseases (3)  ·  Lacrimal Apparatus Diseases (1)  ·  Lens Diseases (1)  ·  Refractive Errors (1)  ·  Retinal Degeneration (1)  ·  Retinal Diseases (1)

Interventions

Ranibizumab (1)

Sponsors

Johnson & Johnson Vision Care, Inc. (2)  ·  Dr. Daniel H. Chang, MD (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Southern College of Optometry (1)

Countries

United States (3)  ·  Canada (1)  ·  United Kingdom (1)

Top investigators

Daniel H Chang, MD (1)  ·  John Chen, MD (1)  ·  John Galic, MD (1)

Results publications

PMID 15625332, PMID 17021318, PMID 17021319, PMID 40276144